MedTrace Logo

Streamlined Localization Using SCOUT® at Biopsy (STREAMLoc )

NCT04815291 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 93

Last updated 2024-05-21

Study results available
· View outcomes & findings →

Summary

This registry is intended to demonstrate the utility of SCOUT® in the Canadian public and US healthcare systems with fixed resources and a conservative approach to patient and clinician exposure to harm. The efficacy and safety of this system will be further assessed, as well as the acceptance of clinicians and patients.

Conditions

Interventions

DEVICE

Receives SCOUT at biopsy

SCOUT Reflector

Sponsors & Collaborators

  • Merit Medical Systems, Inc.

    lead INDUSTRY

Principal Investigators

  • C Desbiens, MD · St. Sacrement

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-04-01
Primary Completion
2024-01-15
Completion
2024-01-15
FDA Device
Yes

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04815291 on ClinicalTrials.gov